Combinational Immunotherapy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Combinational Immunotherapy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Combinational Immunotherapy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase Ib/II, open-label, multi-center, competitive enrollment and dose-escalation study of ALT-801 in a biochemotherapy regimen either containing cisp…
The purpose of this study is to explore the efficacy and safety of hyperbaric oxygen therapy plus Camrelizumab as a second-line treatment in patients with advan…